ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Cash Flow
Eloxx Pharmaceuticals, Inc. (ELOX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -6.3 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.9 | -7.3 | -3.7 | -16 | -31 | -39 | -28 | -35 | -32 | -14 | -4.7 | -6.3 | |
| 0.3 | 0.2 | 0.1 | 0.0 | 0.2 | 0.6 | 0.6 | 1.0 | 0.7 | 0.8 | 0.2 | 0.0 | |
| – | – | – | – | – | – | – | – | 3.0 | 2.0 | 0.5 | 0.2 | |
| 1.0 | -1.1 | -0.2 | 1.1 | 2.2 | -0.6 | -3.4 | -1.0 | -0.1 | 0.8 | -2.4 | 0.5 | |
| 0.0 | 0.1 | 0.0 | 0.2 | 0.2 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 6.3 | |
| 0.6 | -0.3 | – | -0.1 | -0.3 | -34 | 34 | 2.1 | -0.1 | 0.3 | 0.0 | 0.0 | |
| – | – | – | – | – | – | – | – | 0.0 | -9.4 | 3.1 | 1.6 | |
| 8.7 | 4.8 | 1.2 | 38 | 56 | 47 | -3.4 | 51 | 8.8 | -4.1 | 3.4 | 11 | |
| 4.5 | -2.8 | -2.5 | 23 | 25 | -26 | 2.2 | 18 | -23 | -18 | -1.2 | -15 | |
| -4.9 | -7.5 | -3.7 | -16 | -32 | -39 | -28 | -35 | -32 | -14 | -4.7 | -6.3 |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.